Atovaquone/proguanil: the need for family protection

J Travel Med. 2003 May:10 Suppl 1:S8-12; discussion S21. doi: 10.2310/7060.2003.35057.

Abstract

An increasing number of families, including children and the elderly, are seeking more adventurous travel in exotic parts of the world. Holiday destinations now include once-remote regions such as subSaharan Africa and New Guinea. This increase in visits to tropical and subtropical regions, combined with widespread chloroquine-resistant malaria, now places millions of Western travelers at risk of infection annually. At least 30,000 travelers from industrialized countries are reported to contract malaria each year and approximately 1 in 100 travelers who acquire Plasmodium falciparum malaria will die.

Publication types

  • Review

MeSH terms

  • Adult
  • Africa South of the Sahara
  • Aged
  • Antimalarials / administration & dosage
  • Antimalarials / adverse effects
  • Antimalarials / therapeutic use*
  • Atovaquone
  • Child
  • Drug Combinations
  • Drug Resistance
  • Family
  • Humans
  • Malaria / mortality
  • Malaria / prevention & control*
  • Naphthoquinones / administration & dosage
  • Naphthoquinones / adverse effects
  • Naphthoquinones / therapeutic use*
  • New Guinea
  • Proguanil / administration & dosage
  • Proguanil / adverse effects
  • Proguanil / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Travel
  • United States / epidemiology

Substances

  • Antimalarials
  • Drug Combinations
  • Naphthoquinones
  • atovaquone, proguanil drug combination
  • Proguanil
  • Atovaquone